Accumulation of HIV-1 drug resistance after continued virological failure on first-line ART in adults and children in sub-Saharan Africa
Objectives<br/> Limited availability of viral load (VL) monitoring in HIV treatment programmes in sub-Saharan Africa can delay switching to second-line ART, leading to the accumulation of drug resistance mutations (DRMs). The objective of this study was to evaluate the accumulation of resistan...
Main Authors: | Boender, T, Kityo, C, Boerma, R, Hamers, R, Ondoa, P, Wellington, M, Siwale, M, Nankya, I, Kaudha, E, Akanmu, A, Botes, M, Steegen, K, Calis, J, Rinke de Wit, T, Sigaloff, K |
---|---|
Format: | Journal article |
Published: |
Oxford University Press
2016
|
Similar Items
-
Protease Inhibitor Resistance in the First 3 Years of Second-Line Antiretroviral Therapy for HIV-1 in Sub-Saharan Africa
by: Boender, T, et al.
Published: (2016) -
The relative contributions of HIV drug resistance, nonadherence and low-level viremia to viremic episodes on antiretroviral therapy in sub-Saharan Africa
by: Inzaule, SC, et al.
Published: (2020) -
Previous antiretroviral drug use compromises standard first-line HIV therapy and is mediated through drug-resistance
by: Inzaule, S, et al.
Published: (2018) -
Plasma biomarkers of HIV-related systemic inflammation and immune activation in sub-Saharan Africa before and during suppressive antiretroviral therapy
by: Kroeze, S, et al.
Published: (2019) -
When prevention of mother-to-child HIV transmission fails: preventing pretreatment drug resistance in African children
by: Inzaule, S, et al.
Published: (2018)